[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Pages 2509-2510]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01325]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-19-18JC]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Women's Health Needs Study: The Health of
U.S.-Resident Women from Countries with Prevalent Female Genital
Mutilation/Cutting (FGM/C)'' to the Office of Management and Budget
(OMB) for review and approval. CDC previously published a ``Proposed
Data Collection Submitted for Public Comment and Recommendations''
notice on March 20, 2018 to obtain comments from the public and
affected agencies. CDC received three comments related to the previous
notice. This notice serves to allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Women's Health Needs Study: The Health of U.S.-Resident Women from
Countries with Prevalent Female Genital Mutilation/Cutting (FGM/C)--
New--National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Female Genital Mutilation/Cutting (FGM/C) is a practice common in
many countries; in parts of Asia, Africa and the Middle East that can
have severe, deleterious health consequences for women and girls.
Recent studies suggest that more than 500,000 women and girls in the
United States may have been cut or be at risk for FGM/C based on
whether women or their mothers are from countries with high prevalence
of FGM/C. However, this estimate was derived using indirect techniques
that do not account for the differing characteristics of women in the
country of origin versus those who have migrated to the United States,
or any other factors that are likely to affect the prevalence of FGM/C.
Additional major knowledge gaps regarding FGM/C in the United States
include: The prevalence of FGM/C in selected communities in the United
States with high concentrations of residents from countries where FGM/C
is prevalent; women's attitudes about continuance of the practice; and
the health characteristics and needs of women living in the United
States who have experienced FGM/C or are at risk for FGM/C.
This study aims to capture information on women's history of FGM/C,
their experiences with health care services, and their attitudes about
continuation of the FGM/C practice. Findings from this study will be
used to identify public health needs of women and communities in the
United States that are affected by FGM/C, to formulate public health
strategies to meet identified needs, and to inform prevention efforts.
The proposed information collection will include piloting and
conducting a full-scale survey of the health experiences and needs of
women who live in selected communities in the United States with high
concentrations of residents from countries where FGM/C is widely
practiced. The pilot study will be conducted during the first year of
this project and will be used to assess the feasibility of sampling and
recruiting methods for a hard-to-reach population on a sensitive topic.
Based on findings from the pilot, a change request, including necessary
translations, will be submitted to conduct the full study during the
second and third year of this project. The full study is planned to be
implemented in up to five community sites in the United States. The
estimated annualized burden over the three years of this project is 356
hours. There are no costs to respondents other than their time to
participate.
[[Page 2510]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Time per
Type of respondent Form name Total number responses per response
of respondents respondents (hours)
----------------------------------------------------------------------------------------------------------------
Women age 18 to 49 who were born in, WHNS Eligibility 667 1 5/60
or whose mother was born in, an FGM/C Screener.
practicing country.
Women age 18-49 who were born in, or WHNS Questionnaire...... 400 1 45/60
whose mother was born in, an FGM/C
practicing country.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-01325 Filed 2-6-19; 8:45 am]
BILLING CODE 4163-18-P